75
Participants
Start Date
June 30, 2012
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
Seasonal Influenza DNA vaccine
VRC-FLUDNA063-00-VP is composed of 3 closed-circular DNA plasmids that encode for the hemagglutinin (HA) from the following 3 strains: A/California/04/2009 (H1); A/Victoria/361/2011 (H3), and B/Wisconsin/2010. DNA vaccine vials will be supplied at 4 mg/mL in single use vials. The 1 mg dosage is administered as 0.25 mL volume and the 4 mg dosage as a 1 mL volume.
TIV
2012/13 Seasonal Influenza Trivalent Inactivated Vaccine (TIV)
Emory Children's Center, Atlanta
Vanderbilt University, Nashville
The Gamble Program for Clinical Studies, Cincinnati Children's Hospital Medical Center, Cincinnati
Saint Louis University - Doisy Research Center, St Louis
Dartmouth Hitchcock Medical Center, Lebanon
The Emmes Company, LLC
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH